Inhibition by acharan sulphate of angiogenesis in experimental inflammation models
- 1 October 2002
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 137 (4) , 441-448
Abstract
The effects of acharan sulphate, a glycosaminoglycan isolated from the giant African snail Achatina fulica, on angiogenesis in the granulation tissue were analysed using an air pouch‐type carrageenin‐induced inflammation model in rats and a cotton thread‐induced inflammation model in mice. In the carrageenin‐induced inflammation model in rats, intra‐pouch injections of acharan sulphate (5 and 50 μg) inhibited the pouch fluid accumulation and the granulation tissue formation as well as the angiogenesis in the granulation tissue at day 6 in a dose‐dependent manner. The inhibitory effects of acharan sulphate at 50 μg on the pouch fluid accumulation and the leucocyte infiltration into the pouch fluid was not so effective as that of the cyclo‐oxygenase inhibitor indomethacin at 100 μg, but the inhibitory effects of acharan sulphate at 50 μg on the granulation tissue formation and angiogenesis in the granulation tissue were almost the same as those of indomethacin at 100 μg. Acharan sulphate did not affect levels of vascular endothelial growth factor (VEGF) in the granulation tissue and in the pouch fluid at day 6, but indomethacin significantly lowered them. In the cotton thread‐induced inflammation model in mice, injections of acharan sulphate (10 μg) at the site of the cotton thread implantation inhibited the granulation tissue formation and angiogenesis as indomethacin (20 μg) did. Acharan sulphate (10 μg) did not affect levels of VEGF in the cotton thread‐induced granulation tissue at day 5, but indomethacin (20 μg) significantly lowered them. In culture of human vascular endothelial cells, acharan sulphate at 10 and 100 μg ml−1 inhibited VEGF‐induced capillary tube formation. These findings suggest that the inhibitory effect of acharan sulphate on angiogenesis in carrageenin‐ and cotton thread‐induced granulation tissues is not due to the inhibition of VEGF protein induction, but is due to the inhibition of VEGF‐induced vascular tube formation. British Journal of Pharmacology (2002) 137, 441–448. doi:10.1038/sj.bjp.0704886Keywords
This publication has 25 references indexed in Scilit:
- Defective Angiogenesis in the Inflammatory Granulation Tissue in Histidine Decarboxylase–deficient Mice but not in Mast Cell–deficient MiceJournal of Experimental Medicine, 2002
- Enhancement by histamine of vascular endothelial growth factor production in granulation tissue via H2 receptorsBritish Journal of Pharmacology, 2001
- Angiogenesis in Mice with Chronic Airway InflammationThe American Journal of Pathology, 1998
- Glycosaminoglycans Can Influence Fibroblast Growth Factor-2 Mitogenicity without Significant Growth Factor BindingBiochemical and Biophysical Research Communications, 1997
- Heparin Structure and Interactions with Basic Fibroblast Growth FactorScience, 1996
- Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications.Annals of the Rheumatic Diseases, 1992
- Quantitative method for measuring adjuvant-induced granuloma angiogenesis in insulin-treated diabetic mice.Journal of Pharmacobio-Dynamics, 1986
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- The Inflammatory Response to Implantation of Cotton Pellets in the RatJournal of Pharmacy and Pharmacology, 1963